Trium Capital’s Akoya BioSciences AKYA Stock Holding History

Trium Capital’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-605,496	Closed	-$787K	–	54
2025 Q2	$787K	Buy	+605,496	New	+$728K	0.2%	35

Trium Capital's AKYA Position: Q3 2025 in Review

Trium Capital sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 605,496 shares — an estimated $787K sold.

Trium Capital first reported a position in AKYA in Q2 2025 and held it in 1 quarter. The position peaked at $787K in Q2 2025. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.

Trium Capital reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
Trium Capital sold 605,496 Akoya BioSciences shares in Q3 2025, an estimated $787K.
Trium Capital first reported a position in Akoya BioSciences in Q2 2025 and held it in 1 quarter.
Trium Capital's Akoya BioSciences position peaked at $787K in Q2 2025.
0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.

Based on Trium Capital's 13F filing for Q3 2025, filed 16 Oct 2025.